ERBB2 and carcinoma: In contrast to ER-positive luminal tumors and Her2 carcinomas, which can be treated with targeted therapies such as tamoxifen (estrogen antagonist), aromatase inhibitors or anti-Her2 monoclonal antibodies [12], [13], there is no available targeted therapy for TNBC.